Use of Hasf As a Protective Agent Against Ischemic Tissue Damage

A method of inducing a protective response against ischemic tissue damage is carried out by administering to subject a composition comprising an HASF polypeptide. The composition is administered prior to an ischemic event such as myocardial infarction to reduce tissue damage associated with such an event.

Patents:
WO 2,010,105,263

Inventor(s): MIROTSOU MARIA [US]; DZAU VICTOR J [US]; HUANG JING [CA]

Type of Offer: Licensing



« More Medical Patents

---